Patents by Inventor Janet Mertz

Janet Mertz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of ERRalpha phosphorylation status as a breast cancer biomarker
    Publication number: 20050118658
    Abstract: The inventors discovered that the ErbB2 signal transduction pathway can activate ERR? by inducing its phosphorylation. Based on this discovery, the present invention provides methods for determining whether a breast cancer patient is likely to respond to hormonal-blockade therapy or ErbB2-based therapy, methods for determining prognosis of breast cancer patients, methods for treating breast cancer, and methods for identifying agents that can modulate ERR? phosphorylation.
    Type: Application
    Filed: September 16, 2004
    Publication date: June 2, 2005
    Inventors: Janet Mertz, Eric Ariazi, Richard Kraus